Methionine adenosyltransferase I/III deficiency: neurological manifestations and relevance of S-adenosylmethionine (Q38040977)

27 August 2017

Methionine adenosyltransferase I/III deficiency: neurological manifestations and relevance of S-adenosylmethionine (English)

1 reference

27 August 2017

Mahoko Furujo

1

1 reference

27 August 2017

Masako Kinoshita

series ordinal

2

1 reference

27 August 2017

Masayoshi Nagao

series ordinal

3

1 reference

27 August 2017

Toshihide Kubo

series ordinal

4

1 reference

27 August 2017

11 August 2012

1 reference

Molecular Genetics and Metabolism

27 August 2017

1 reference

27 August 2017

107

1 reference

27 August 2017

3

1 reference

27 August 2017

253-256

1 reference

Inherited disorders in the conversion of methionine to homocysteine

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Characterization of a full-length cDNA encoding human liver S-adenosylmethionine synthetase: tissue-specific gene expression and mRNA levels in hepatopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Normal brain myelination in a patient homozygous for a mutation that encodes a severely truncated methionine adenosyltransferase I/III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Hypermethioninemias of genetic and non-genetic origin: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

S-adenosylmethionine treatment in methionine adenosyltransferase deficiency, a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Methionine adenosyltransferase deficiency: new enzymatic defect associated with hypermethioninemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Isolation of a cDNA encoding the rat liver S-adenosylmethionine synthetase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Atypical BECTS and homocystinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Effect of vitamin B6 deficiency on the synthesis and accumulation of S-adenosylhomocysteine and S-adenosylmethionine in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.08.002

10.1016/J.YMGME.2012.08.002

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference